Reasons to attend
The course is divided into different modules addressing the basic science of oncology, clinical oncology, therapeutic modalities, and clinical trials in oncology. Exercises for self-assessment are used to enhance your understanding of the main topics discussed in the course. You will be able to test your comprehension with a final grading assessment.
- Documents and materials related to this course are included
- Globally recognised certificates awarded after test completion
- This course has been granted PharmaTrain Recognition
2-Day Face-to-face: 09h00 to 17h00
Webinars: 4 sessions of 3 hours
- 9 September - 15:00 to 18:00
- 10 September - 15:30 to 18:30
- 13 September - 15:00 to 18:00
- 14 September - 15:00 to 18:00
Do you want to shift your career toward clinical research in oncology? Do you have some previous knowledge of this field but need to organize and structure this knowledge, so you can take a step forward? This course provides you with the grounding that will allow you to understand the most salient aspects of the basic and clinical sciences that support clinical research in oncology and haematological malignancies.
During this course in which lectures are alternated with interactive sessions with the students, you receive instruction on cancer biology, clinical oncology, and clinical research issues that are particular to oncology. These include the genetic and epigenetic basis of cancer, the classification and staging of tumours, the diagnosis, treatment and follow-up of patients, and the most important instruments used in oncology clinical trials, such as methods of response evaluation, toxicity assessment, and survival endpoints. The workshops will be done in the second part of the course.
Numerous examples are used to provide you with sufficient insight on the impact of cancer on patients’ health, how cancer is tackled from a surgical, medical, and radiotherapeutic point of view, and how clinical research in oncology follows a structured pathway that relies on knowledge about the essence of cancer as a biological phenomenon.